Position in NRIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,319,466
+$1,163,528 QoQ
Shares Held
178,049
-12.6% QoQ
Ownership
0.172%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 210 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 0%
Shared 99%
None 1%
Common Shares in NRIX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,026 across 296 Biotechnology names. NRIX ranks #87 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in NRIX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,319,466 | 178,049 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,155,938 | 203,609 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $6,522,453 | 343,830 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $1,477,668 | 159,921 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,563,515 | 137,271 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,397,502 | 117,635 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $979,302 | 51,980 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $9,287,748 | 413,340 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $7,623,768 | 365,298 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $4,599,776 | 312,910 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $524,513 | 50,825 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $372,594 | 47,404 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $476,841 | 47,732 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $430,093 | 48,434 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $167,422 | 15,248 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $199,071 | 15,278 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $168,472 | 13,297 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $187,018 | 13,349 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $381,299 | 13,171 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $480,077 | 16,024 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $357,730 | 13,484 | Shares | Defined | 2021-08-17 | |
| No filing history on record for this holder in this stock. | ||||||